Promoter holding
64.27%
SB
Satyavathi Bio-Life Sciences Limited - Due diligence report
A 360° intelligence report on Satyavathi Bio-Life Sciences Limited: trust score, financial health, credit view, compliance, directors, growt…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Satyavathi Bio-Life Sciences Limited — 360° Intelligence Report
Generated from MCA filings & public records51/100
Trust Score
Moderate
Satyavathi Bio-Life Sciences Limited is assessed as Moderate with a Trust Score of 51/100. Satyavathi Bio-Life Sciences Limited is a public limited indian non-government company incorporated in 2005, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.
Report generated on 12 Aug 2026 from the latest processed filings. Satyavathi Bio-Life Sciences Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
51/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
25/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
- Externally credit-rated (B).
Charges position: 0 open (-) · 1 satisfied (5.00 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| State Bank Of India | 1 | 48.0 cr |
Compliance Score: 30/100 Caution Indicated
- Company status is "Strike Off" - not Active.
- Last balance sheet is for Mar 2022 - filings overdue.
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| JANAKI YALAMANCHILI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| YALAMANCHILI SRINIVASA NAVEEN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DILEEP KUMAR PENDURTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Bliss Llc Usa | Subsidiary Company | 74.00% |
Key managerial personnel: YALAMANCHILI SRINIVASA NAVEEN (Managing Director) · DILEEP KUMAR PENDURTY (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 25
Growth signals & trust indicators
Operating for 20+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (30/100).
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence35/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 4 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment44/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view43/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2022
Last AGM held
Annual general meeting
31 Mar 2022
Latest balance sheet
Filed with ROC
30 Sep 2019
Director ceased
JANAKI YALAMANCHILI
01 Sep 2019
Director ceased
ANIL KUMAR KESARAJU
Director ceased
VENKATARAMANA RAJU KANUMURI
20 Jun 2019
Director appointed
JANAKI YALAMANCHILI (Director)
Director ceased
RAMESH MALLU
20 May 2019
Director ceased
DILEEP KUMAR PENDURTY
05 Apr 2019
Securities allotted
25600000 Equity Shares Without Differential Rights - 25.60 cr raised
03 Aug 2018
Charge satisfied
State Bank Of India
26 Mar 2018
Director appointed
DILEEP KUMAR PENDURTY (Whole-time director)
Director ceased
RAGHAVAKAIMAL PADMAKUMAR
23 Mar 2015
Securities allotted
1350000 Equity Shares Without Differential Rights - 1.35 cr raised
31 Mar 2014
Securities allotted
9500000 Equity Shares Without Differential Rights - 9.50 cr raised
01 Nov 2013
Director ceased
SUNDER VENKATRAMAN
10
Key Observations
Auto-generated from the data aboveRevenue declined 38% over the last 4 financial year(s).
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
Carries an external credit rating of B from Crisil.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| C.C. Polycoats India Private Limited | U74900PN2011PTC138514 | Satara, Maharashtra, India |
| Solar Interchem Pvt Ltd | U24200MH1982PTC028349 | Mumbai, Maharashtra, India |
| Shree Abhinav Flower Distillers Private Limited | U24244UP2006PTC031378 | Kanpur, Uttar Pradesh, India |
| Bombay Biosyntex Chemicals Private Limited | U74900MH2000PTC126639 | Mumbai, Maharashtra, India |
| Micha Life Sciences Private Limited | U73100TN2019PTC127270 | Chennai, Tamil Nadu, India |
| Silvo Liacal Chemicals Pvt Ltd | U24110MH1983PTC029454 | Mumbai, Maharashtra, India |
| Aldehydes India Private Limited | U24119HR1996PTC033075 | Haryana, Haryana, India |
| Dyna Biotech | U24303PN2016PTC165173 | Pune, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Satyavathi Bio-Life Sciences Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Satyavathi Bio-Life Sciences Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Satyavathi Bio-Life Sciences Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 51/100, distress signals and MSME payment-delay disclosures - know whether Satyavathi Bio-Life Sciences Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Satyavathi Bio-Life Sciences Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Satyavathi Bio-Life Sciences Limited an active company?
Satyavathi Bio-Life Sciences Limited has MCA status “Strike Off” with a compliance score of 30/100 (Caution Indicated).
Is Satyavathi Bio-Life Sciences Limited financially healthy?
Satyavathi Bio-Life Sciences Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Satyavathi Bio-Life Sciences Limited?
Its overall Trust Score is 51/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Satyavathi Bio-Life Sciences Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Satyavathi Bio-Life Sciences Limited have loans or charges against its assets?
No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Satyavathi Bio-Life Sciences Limited up to date with its ROC filings?
Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).
Is it risky to lend to Satyavathi Bio-Life Sciences Limited?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
